
The study analyzed the accuracy of nasal pressure swing (ΔPnose) in predicting early (24-hour) failure of high-flow nasal oxygen (HFNO) to treat acute hypoxemic respiratory failure (AHRF). The study concluded that ΔPnose has high accuracy in predicting HFNO failure at T2 and can provide an accurate quantification of the patient's inspiratory effort, which can help monitor the risk of deterioration during AHRF treatment. The study also found that ΔPnose was a better predictor of failure than composite indices such as the respiratory rate-oxygenation (ROX) index.
Like
Save
Share